Clinical Trial Update: Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1) [EARLY_Phase 1]

View source ↗

Summary

This entry notes an early-phase 1 study of YOLT-203 for Type 1 primary hyperoxaluria, with the trial currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Primary Hyperoxaluria

Drugs mentioned

• YOLT-203

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Type 1 Primary Hyperoxaluria | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING